Articles by Disease (Cerebellar Diseases)

Neurotoxicity Associated with Platinum-Based Anti-Cancer Agents: What are the Implications of Copper Transporters?

Journal: Current Medicinal Chemistry
Volume: 24
Page: 1520-1536
Author(s): Vanesa Stojanovska, Rachel McQuade, Emma Rybalka and Kulmira Nurgali*

Recent Advances in Targeted Therapy for Glioma

Journal: Current Medicinal Chemistry
Volume: 24
Page: 1365-1381
Author(s): Lin Lin, Jinquan Cai* and Chuanlu Jiang*

Homocysteine in Neurology: From Endothelium to Neurodegeneration

Journal: Current Nutrition & Food Science
Volume: 13
Page: 163-175
Author(s): Rita Moretti*, Matteo Dal Ben, Silvia Gazzin and Claudio Tiribelli

Clinical and Environmental Correlates of Serum BDNF: A Descriptive Study with Plausible Implications for AD Research

Journal: Current Alzheimer Research
Volume: 14
Page: 722-730
Author(s): Galit Weinstein*, Sarah R. Preis, Alexa S. Beiser, Bernhard Kaess, Tai C. Chen, Claudia Satizabal, Faisal Rahman, Emelia J. Benjamin, Ramachandran S. Vasan and Sudha Seshadri

Tauopathies – Focus on Changes at the Neurovascular Unit

Journal: Current Alzheimer Research
Volume: 14
Page: 790-801
Author(s): Alena Michalicova, William A. Banks, Jaroslav Legath and Andrej Kovac*

Targeting Vascular Neural Network in Intracerebral Hemorrhage

Journal: Current Pharmaceutical Design
Volume: 23
Page: 2197-2205
Author(s): Yi Yin, Hongfei Ge, John H. Zhang* and Hua Feng*

InsP3 Signaling in Apicomplexan Parasites

Journal: Current Topics in Medicinal Chemistry
Volume: 17
Page: 2158-2165
Author(s): Celia R.S. Garcia*, Eduardo Alves, Pedro H. S. Pereira, Paula J. Bartlett, Andrew P. Thomas, Katsuhiko Mikoshiba, Helmut Plattner and L. David Sibley

Distribution of Synthetic Cannabinoids JWH-210, RCS-4 and Δ 9-Tetrahydrocannabinol After Intravenous Administration to Pigs

Journal: Current Neuropharmacology
Volume: 15
Page: 713-723
Author(s): Nadine Schaefer*, Mattias Kettner, Matthias W. Laschke, Julia Schlote, Andreas H. Ewald, Michael D. Menger, Hans H. Maurer and Peter H. Schmidt

Glycogen Synthase Kinase-3: A Potential Target for Drug Discovery in the Treatment of Neurodegenerative Disorders

Journal: Current Enzyme Inhibition
Volume: 13
Page: 107-128
Author(s): Darshit B. Shah and M. Ramanathan*

Recombinant Antibody Fragments for Neurodegenerative Diseases

Journal: Current Neuropharmacology
Volume: 15
Page: 779-788
Author(s): Karen Manoutcharian, Roxanna Perez-Garmendia and Goar Gevorkian*